Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1A | P35348 | 4/20 | 0.53 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.44 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.44 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.44 |
| ▸ | HTR2B | P41595 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.39 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.39 |
| ▸ | NISCH | Q9Y2I1 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | F2RL1 | P55085 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | GFER | P55789 | 1/20 | 0.37 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.36 |
| ▸ | CDK1 | P06493 | 1/20 | 0.36 |
| ▸ | CDK4 | P11802 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7856564 | 1.00 | ADRA1A (0.53) | ADRA1AADRA2AADRA1DADRA1BHTR2B | |
| SCHEMBL1133528 | 1.00 | ADRA1A (0.53) | ADRA1AADRA2AADRA1DADRA1BHTR2B | |
| Hydrochloric Acid SCHEMBL11394021 | 0.98 | ADRA1A (0.52) | ADRA1AADRA2AADRA1DADRA1BHTR2B | |
| SCHEMBL184451 | 0.98 | ADRA1A (0.55) | ADRA1AADRA2AADRA1DADRA1BHTR2B | |
| SCHEMBL1494449 | 0.93 | — | — | |
| SCHEMBL196337 | 0.89 | — | — | |
| SCHEMBL16512331 | 0.82 | ADRA1A (0.49) | ADRA1AADRA2AADRA1DADRA1BHTR2B | |
| SCHEMBL7809418 | 0.81 | ADRA1A (0.52) | ADRA1AADRA2AADRA1DADRA1BHTR2B | |
| SCHEMBL4585762 | 0.81 | ADRA1A (0.52) | ADRA1AADRA2AADRA1DADRA1BHTR2B | |
| SCHEMBL2488698 | 0.81 | ADRA1A (0.52) | ADRA1AADRA2AADRA1DADRA1BHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 256 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119869890-A | Coloring process for solar photovoltaic solder strip | 盐城国投新材料有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119661817-A | Synthetic method of liquid crystal polyarylester and application of high-boiling-point imidazole catalyst in synthesis of liquid crystal polyarylester | 浙江聚领新材料有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-116535616-A | Phosphorus-containing imidazole oligomer flame-retardant curing agent and application thereof in flame-retardant epoxy resin | 浙大宁波理工学院 | 2023-08-04 | — | — | CN | claimed |
| CN-113185736-A | Polyelectrolyte material for new energy automobile fuel cell and preparation method thereof | 邓文辉 | 2021-07-30 | — | — | CN | claimed |
| EP-2585473-B1 | METAL PHOSPHONATE FLAME RETARDANT AND METHOD PRODUCING THEREOF | ICL IP AMERICA INC (US) | 2015-09-23 | — | — | EP | claimed |
| US-8889773-B2 | Metal phosphonate flame retardant and method producing thereof | ICL-IP AMERICA INC. (US) | 2014-11-18 | — | — | US | claimed |
| US-20130165564-A1 | METAL PHOSPHONATE FLAME RETARDANT AND METHOD PRODUCING THEREOF | ICL-IP AMERICA INC. (US) | 2013-06-27 | — | — | US | claimed |
| WO-2013077989-A1 | PROCESS FOR PREPARATION OF ALUMINUM SALT OF PHOSPHONIC ACID ESTER | ICL-IP AMERICA INC. (US) | 2013-05-30 | — | — | WO | claimed |
| EP-2585473-A2 | METAL PHOSPHONATE FLAME RETARDANT AND METHOD PRODUCING THEREOF | ICL-IP America Inc. (US) | 2013-05-01 | — | — | EP | claimed |
| CN-103003289-A | Metal Phosphonate Flame Retardant And Method Producing Thereof | ICL IP AMERICA INC | 2013-03-27 | — | — | CN | claimed |
| WO-2011163207-A2 | METAL PHOSPHONATE FLAME RETARDANT AND METHOD PRODUCING THEREOF | ICL-IP AMERICA INC. (US) | 2011-12-29 | — | — | WO | claimed |
| JP-2003511456-A | — | — | 2003-03-25 | — | — | JP | claimed |
| EP-1218383-A2 | BICYCLIC IMIDAZO-5-YL-AMINE DERIVATIVES | Grünenthal GmbH (DE) | 2002-07-03 | — | — | EP | claimed |
| WO-2001027118-A2 | BICYCLIC IMIDAZO-5-YL-AMINE DERIVATIVES | Grünenthal GmbH (DE) | 2001-04-19 | — | — | WO | claimed |
| US-4925901-A | STORAGE STAABILITY, ONIUM ION CATALYST | THE DOW CHEMICAL COMPANY (US) | 1990-05-15 | — | — | US | claimed |
| CN-119869890-A | Coloring process for solar photovoltaic solder strip | 盐城国投新材料有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-119661817-A | Synthetic method of liquid crystal polyarylester and application of high-boiling-point imidazole catalyst in synthesis of liquid crystal polyarylester | 浙江聚领新材料有限公司 | 2025-03-21 | — | — | CN | disclosed |
| EP-0005868-A1 | Water-soluble reactive binding agents, process for their preparation and their use in the manufacture of coatings and adhesives | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-12-12 | — | — | EP | disclosed |
| EP-0002284-A1 | Reactive curable polymer mixture and process for preparing cured products therefrom | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-06-13 | — | — | EP | disclosed |
| US-3932444-A | PLASTICIZERS | E. I. DU PONT DE NEMOURS & CO. (US) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130165564-A1 | METAL PHOSPHONATE FLAME RETARDANT AND METHOD PRODUCING THEREOF | MTAP, AS3MT, MPHOSPH6 | ADRA1A 4480/4885ADRA2A 4525/4885ADRA1D 4742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.